Liquid Crystalline Systems for Transdermal Delivery of Celecoxib: In Vitro Drug Release and Skin Permeation Studies
- 487 Downloads
Liquid crystalline systems of monoolein/water could be a promising approach for the delivery of celecoxib (CXB) to the skin because these systems can sustain drug release, improve drug penetration into the skin layers and minimize side effects. This study evaluated the potential of these systems for the delivery of CXB into the skin based on in vitro drug release and skin permeation studies. The amount of CXB that permeated into and/or was retained in the skin was assayed using an HPLC method. Polarizing light microscopy studies showed that liquid crystalline systems of monoolein/water were formed in the presence of CXB, without any changes in the mesophases. The liquid crystalline systems decreased drug release when compared to control solution. Drug release was independent of the initial water content of the systems and CXB was released from cubic phase systems, irrespective of the initial water content. The systems released the CXB following zero-order release kinetics. In vitro drug permeation studies showed that cubic phase systems allowed drug permeation and retention in the skin layers. Cubic phase systems of monoolein/water may be promising vehicles for the delivery of CXB in/through the skin because it improved CXB skin permeation compared with the control solution.
KEY WORDScelecoxib drug delivery systems liquid crystalline system monoolein skin permeation
The authors thank Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) e Universidade de São Paulo (USP), Brazil for supporting this study.
Conflict of interest
The authors report no declarations of interest.
- 7.Sharma PK, Bajpai M. Enhancement of solubility and stability of Celecoxib using microemulsion based topical formulation. J Pharm Res. 2011;4:2216–20.Google Scholar
- 8.Quiñones OG, Mata Dos Santos HA, Kibwila DM, Leitão A, Dos Santos Pyrrho A, Pádua MD et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Drug Dev Ind Pharm 2013. doi: 10.3109/03639045.2013.809731.
- 17.Steluti R, De Rosa FS, Collett J, Tedesco AC, Bentley MVLB. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur J Pharm Biopharm. 2005;60:439–44.PubMedCrossRefGoogle Scholar